Viewing Study NCT00392834


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2025-12-26 @ 1:05 AM
Study NCT ID: NCT00392834
Status: COMPLETED
Last Update Posted: 2018-06-06
First Post: 2006-10-25
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma
Sponsor: AIDS Malignancy Consortium
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-09
Start Date Type: None
Primary Completion Date: 2011-07
Primary Completion Date Type: ACTUAL
Completion Date: 2013-07
Completion Date Type: ACTUAL
First Submit Date: 2006-10-25
First Submit QC Date: None
Study First Post Date: 2006-10-26
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2013-01-24
Results First Submit QC Date: None
Results First Post Date: 2013-02-28
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-05-03
Last Update Post Date: 2018-06-06
Last Update Post Date Type: ACTUAL